Identification and frequency of circulating CD4+ T lymphocytes specific to Benzylpenicillin in healthy donors

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 7, 2013, Pages 899-905

  Nhim, C ^a   Delluc, S ^b   Halgand, F ^c   De Chaisemartin, L ^a,d   Weaver, R J ^e   Claude, N ^e   Joseph, D ^a   Maillere B ^f   Pallardy, M ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Indicia Biotechnology   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d BICHAT HOSPITAL   (France)

^e Institut de Recherches Internationales   (France)

^f Institute Frederic Joliot   (France)

Author keywords

benzylpenicillin; drug allergy; T lymphocytes

Indexed keywords

GAMMA INTERFERON; HAPTEN; HLA DRB1 ANTIGEN; PENICILLIN G;

ALLOTYPE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL;

BENZYLPENICILLIN; DRUG ALLERGY; T LYMPHOCYTES;

ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; DENDRITIC CELLS; DRUG HYPERSENSITIVITY; ENZYME-LINKED IMMUNOSPOT ASSAY; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; PENICILLIN G; REFERENCE VALUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84880265732     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12173     Document Type: Article

References (30)

1. Bigby M, Jick S, Jick H, Arndt K,. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358-3363.
2. Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, Delacourt C, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol 2011; 22: 411-418.
3. Weltzien HU, Padovan E,. Molecular features of penicillin allergy. J Invest Dermatol 1998; 110: 203-206.
4. Padovan E, Bauer T, Tongio MM, Kalbacher H, Weltzien HU,. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997; 27: 1303-1307.
5. Padovan E, Mauri-Hellweg D, Pichler WJ, Weltzien HU,. T cell recognition of penicillin G: structural features determining antigenic specificity. Eur J Immunol 1996; 26: 42-48.
6. Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ,. Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 1995; 155: 2670-2678.
7. Meng X, Jenkins RE, Berry NG, Maggs JL, Farrell J, Lane CS, et al. Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients. J Pharmacol Exp Ther, 2011; 338: 841-849.
8. Yvon M, Wal JM,. Identification of lysine residue 199 of human serum albumin as a binding site for benzylpenicilloyl groups. FEBS Lett 1988; 239: 237-240.
9. Yvon M, Anglade P, Wal JM,. Binding of benzyl penicilloyl to human serum albumin. Evidence for a highly reactive region at the junction of domains 1 and 2 of the albumin molecule. FEBS Lett 1989; 247: 273-278.
10. Yvon M, Anglade P, Wal JM,. Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin, on the serum albumin molecule. FEBS Lett 1990; 263: 237-240.
11. Jenkins MK, Chu HH, McLachlan JB, Moon JJ,. On the composition of the preimmune repertoire of T cells specific for Peptide-major histocompatibility complex ligands. Annu Rev Immunol 2010; 28: 275-294.
12. Delluc S, Ravot G, Maillere B,. Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors. Faseb J 2011; 25: 2040-2048.
13. Delluc S, Ravot G, Maillere B,. Quantification of the preexisting CD4 T-cell repertoire specific for human erythropoietin reveals its immunogenicity potential. Blood 2010; 116: 4542-4545.
14. Laroche D, Chollet-Martin S, Leturgie P, Malzac L, Vergnaud MC, Neukirch C, et al. Evaluation of a new routine diagnostic test for immunoglobulin e sensitization to neuromuscular blocking agents. Anesthesiology 2011; 114: 91-97.
15. Torres MJ, Blanca M, Fernandez J, Romano A, Weck A, Aberer W, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58: 961-972.
16. Torres MJ, Mayorga C, Pamies R, Rodriquez JL, Juarez C, Romano A, et al. Immunologic response to different determinants of benzylpenicillin, amoxicillin, and ampicillin. Comparison between urticaria and anaphylactic shock. Allergy 1999; 54: 936-943.
17. Blanca M, Mayorga C, Torres MJ, Reche M, Moya MC, Rodriguez JL, et al. Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy 2001; 56: 862-870.
18. Blanca M, Romano A, Torres MJ, Fernandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64: 183-193.
19. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007; 27: 203-213.
20. Hataye J, Moon JJ, Khoruts A, Reilly C, Jenkins MK,. Naive and memory CD4+ T cell survival controlled by clonal abundance. Science 2006; 312: 114-116.
21. Geiger R, Duhen T, Lanzavecchia A, Sallusto F,. Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med 2009; 206: 1525-1534.
22. Jenkins RE, Meng X, Elliott VL, Kitteringham NR, Pirmohamed M, Park BK,. Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo. Proteomics Clin Appl 2009; 3: 720-729.
23. Whitaker P, Meng X, Lavergne SN, El-Ghaiesh S, Monshi M, Earnshaw C, et al. Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis. J Immunol 2011; 187: 200-211.
24. Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T,. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab. Arthritis Rheum 2006; 54: 3782-3789.
25. Radstake TR, Svenson M, Eijsbouts AM, van den Hoogen FH, Enevold C, van Riel PL, et al. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. Ann Rheum Dis 2009; 68: 1739-1745.
26. Baert F, Noman M, Vermeire S, Van Assche G, G DH, Carbonez A, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003; 348: 601-608.
27. Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, et al. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. Ann Rheum Dis 2007; 66: 921-926.
28. Bender NK, Heilig CE, Droll B, Wohlgemuth J, Armbruster FP, Heilig B,. Immunogenicity, efficacy and adverse events of adalimumab in RA patients. Rheumatol Int 2007; 27: 269-274.
29. Rozieres A, Hennino A, Rodet K, Gutowski MC, Gunera-Saad N, Berard F,. Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 2009; 64: 534-542.
30. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G, Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003; 171: 5760-5768.